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Painful bladder syndrome/interstitial cystitis (PBS/IC) encom-
passes a major portion of the “painful bladder” disease complex. 
“Painful bladder disorders” comprise a large group of patients 
with bladder and/or urethral and/or pelvic pain, irritative void-
ing symptoms (urgency, frequency, nocturia, and dysuria), and 
sterile urine cultures. Painful bladder conditions with well-es-
tablished causes include radiation cystitis, cystitis caused by mi-
croorganisms that are not detected by routine culture method-
ologies, and systemic disorders that affect the bladder. In addi-
tion, many gynecologic disorders can mimic PBS/IC [1]. PBS/
IC has no easily discernible etiology. There are no pathognomon-
ic findings on pathologic examination, and even the detection 
of petechial hemorrhages on the bladder mucosa during cys-
toscopy after bladder hydrodistention under anesthesia is no 
longer considered the sine qua non of PBS/IC that it had been 
until a decade ago [2]. PBS/IC is truly a diagnosis by exclusion. 
It may have multiple causes and represent a final common reac-
tion of the bladder to different types of insult. There are numer-
ous theories regarding its pathogenesis, but confirmatory evi-
dence found in clinical practice has proven sparse. Among nu-
merous proposals that have been further studied are leaky epi-
thelium, mast cell activation, neurogenic inflammation, inhibi-
tion of uroepithelial cell proliferation: antiproliferative factor 
(APF), nitric oxide metabolism, urine abnormality and the role 
of genetics or some combination of these and other factors lead-
ing to a self-perpetuating process resulting in chronic bladder 
pain and voiding dysfunction [3]. Among the various possible 
evidences, APF has recently been the subject of much attention. 
The finding that cells from the bladder lining of normal controls 
grow significantly more rapidly in culture than cells from PBS/
IC patients led Keay et al. [4] at the University of Maryland to 
the discovery of an APF produced by the urothelium of IC pa-
tients. Studies are ongoing to confirm the hypotheses related to 
APF and expand on its significance in diagnosis and develop-
ment of a rational targeting treatment approach. Especially, the 
article by Kim and Freeman [5] in this issue of the journal will 
be recognized as a valuable update on signal transduction path-
ways and networks that are responsive to APF to learning more 
about potential therapeutic pathways. 
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